📌 Key Takeaways
- Topic: Silica Supplier Korea: Key Producers, Demand Sectors and Import Options
- Keywords: quartz
- Published: 2026-11-20 08:57:51
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Ultra Pure Silica: What Purity Level You Need and Which Industries Use It
- Silica HS Code: Correct Customs Classification for Silica, Quartz and Silica Gel
- Spherical Silica Manufacturer: Key Capabilities, Purity Control and Selection Criteria
- What Is Diatomite? Properties, Filtration Uses and Industrial Applications
- Silica for Epoxy Molding Compound (EMC): Spherical Silica Specs and Selection
What Is TEOS? Uses in Sol-Gel Silica, Coatings and Semiconductors
What is silica (SiO₂)?
how is silica made
What is the difference between fumed silica and precipitated silica?
hydrophobic silica powder 58. Kinnari P., Mäkilä E., Heikkilä T., Salonen J., Hirvonen J., Santos H.A. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int. J. Pharm. 2011;414:148-156. doi: 10.1016/j.ijpharm.2011.05.021. [ DOI ] [ PubMed ] [ Google Scholar ]
What drives silica raw material prices?
silica particle size In recent years, mesoporous silica nanocarriers have attracted great interest in pharmaceutical science because of their advantageous properties. Straightforward synthesis, low production cost, and tunable physicochemical properties characterize them. Their behavior in the human body, including targeting possibilities, can be influenced by particle size, particle morphology, pore size, internal structure, and surface chemistry. By modifying the surface functional groups and the surface charge, targeted therapy is achievable in several medical conditions. A wide range of drug loading methods is available (whether solvent-based or solvent-free techniques), so the most appropriate method can be selected, and higher drug concentration can be encapsulated, enhancing loading efficiency. Nevertheless, their formulation for different delivery routes, such as dermal, pulmonary, or the most favorable oral administration, is very difficult due to their large particular surface, adhesivity, and low density, which leads to poor powder flow properties, posing a huge difficulty in the manufacturing and formulation of solid dosage forms. Agglomeration of the particles by granulation or pelletization is a brilliant remedy for enhancing flowability. Concluding this, the granulation process of mesoporous silica has to be investigated and optimized to sustain the initially high porosity and high particular surface area of the material.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.